ST. LOUIS, Feb. 13, 2012 /PRNewswire/ -- With its markets
still facing tight budget constraints, Allied Healthcare Products
(NASDAQ: AHPI) reported break-even results for the second quarter
of fiscal year 2012.
Net income for the quarter ending December 31, was about $23,000, or zero cents per basic and diluted
share, versus $117,000, or
1 cent per basic and diluted share
for the prior year. Sales for the quarter declined from about
$11.4 million to $10.7 million, or
about 6.1 percent, from the previous year.
For the first two quarters of fiscal 2012, net income was a
negative $122,000, or a negative
2 cents per basic and diluted share,
compared to net income of $29,000, or
zero cents per basic and diluted share, for the prior year. Sales
for the first two quarters slipped from about $23.3 million to $22.1 million, or about 5.2
percent, from the previous year.
Sales declines in other markets were partially offset by
increases in domestic hospital construction and international
markets of 12 and 4 percent, respectively, Allied reported.
Increases in costs for commodities such as brass and plastic
resin totaled about 8 percent or $110,000 in the first two quarters. Material cost
increases were offset by cost reduction projects which reduced
manufacturing costs by $160,000 for
the two quarters.
"We expect to achieve further cost reductions in operations in
the second half of the fiscal year from projects we have underway,"
said Earl Refsland, Allied
Healthcare Products president and chief executive officer.
Allied Healthcare Products manufactures a variety of respiratory
products used in the healthcare industry in a range of hospital and
alternate care settings including sub-acute facilities, home
healthcare and emergency medical care. Allied product lines include
respiratory care products, medical gas equipment and emergency
medical products. Allied products are marketed to hospitals,
hospital equipment dealers, hospital construction contractors, home
healthcare dealers and emergency medical product dealers.
"SAFE HARBOR" STATEMENT: Statements contained in this release
that are not historical facts or information are "forward-looking
statements." Words such as "believe," "expect," "intend,"
"will," "should," and other expressions that indicate future events
and trends identify such forward-looking statements. These
forward-looking statements involve risks and uncertainties that
could cause the outcome and future results of operations and
financial condition to be materially different than stated or
anticipated based on the forward-looking statements. Such risks and
uncertainties include both general economic risks and
uncertainties, risks and uncertainties affecting the demand for and
economic factors affecting the delivery of health care services,
and specific matters which relate directly to the Company's
operations and properties as discussed in its periodic filings with
the Securities and Exchange Commission. The Company cautions that
any forward-looking statement contained in this report reflects
only the belief of the Company or its management at the time the
statement was made. Although the Company believes such
forward-looking statements are based upon reasonable assumptions,
such assumptions may ultimately prove inaccurate or incomplete. The
Company undertakes no obligation to update any forward-looking
statement to reflect events or circumstances after the date on
which the statement was made.
|
|
ALLIED
HEALTHCARE PRODUCTS, INC.
|
|
CONSOLIDATED
STATEMENT OF OPERATIONS
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended,
|
|
Six months
ended,
|
|
|
December
31,
|
|
December
31,
|
|
|
2011
|
|
2010
|
|
2011
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
$10,681,395
|
|
$11,402,681
|
|
$22,076,403
|
|
$23,343,414
|
|
Cost of sales
|
7,946,458
|
|
8,592,712
|
|
16,935,449
|
|
17,982,718
|
|
Gross profit
|
2,734,937
|
|
2,809,969
|
|
5,140,954
|
|
5,360,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling General and
administrative expenses
|
2,693,894
|
|
2,600,734
|
|
5,327,983
|
|
5,285,310
|
|
Income (loss) from
operations
|
41,043
|
|
209,235
|
|
(187,029)
|
|
75,386
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
(7,297)
|
|
(8,067)
|
|
(16,292)
|
|
(15,542)
|
|
Interest expense
|
-
|
|
-
|
|
336
|
|
66
|
|
Other, net
|
11,743
|
|
28,410
|
|
26,149
|
|
43,509
|
|
|
4,446
|
|
20,343
|
|
10,193
|
|
28,033
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before provision
for
|
|
|
|
|
|
|
|
|
(benefit from) income
taxes
|
36,597
|
|
188,892
|
|
(197,222)
|
|
47,353
|
|
|
|
|
|
|
|
|
|
|
Provision for (benefit from)
income taxes
|
13,907
|
|
71,779
|
|
(74,944)
|
|
17,994
|
|
Net income (loss)
|
$22,690
|
|
$117,113
|
|
($122,278)
|
|
$29,359
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share -
Basic
|
$0.00
|
|
$0.01
|
|
($0.02)
|
|
$0.00
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share -
Diluted
|
$0.00
|
|
$0.01
|
|
($0.02)
|
|
$0.00
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
outstanding - Basic
|
8,124,386
|
|
8,098,366
|
|
8,124,386
|
|
8,095,876
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
outstanding - Diluted
|
8,124,834
|
|
8,119,386
|
|
8,124,386
|
|
8,114,724
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ALLIED
HEALTHCARE PRODUCTS, INC.
|
|
|
CONSOLIDATED
BALANCE SHEET
|
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
December 31,
2011
|
|
June 30,
2011
|
|
ASSETS
|
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash and cash
equivalents
|
$
6,251,364
|
|
$
6,512,887
|
|
|
Accounts receivable, net of
allowances
|
|
|
|
|
|
of $300,000
|
4,211,786
|
|
5,366,860
|
|
|
Inventories, net
|
11,072,733
|
|
10,553,289
|
|
|
Income tax receivable
|
169,507
|
|
95,578
|
|
|
Other current assets
|
503,979
|
|
213,745
|
|
|
Total current
assets
|
22,209,369
|
|
22,742,359
|
|
|
Property, plant and equipment,
net
|
8,952,244
|
|
8,660,507
|
|
|
Other assets, net
|
356,359
|
|
362,480
|
|
|
Total
assets
|
$
31,517,972
|
|
$
31,765,346
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS'
EQUITY
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
Accounts payable
|
$
2,027,981
|
|
$
1,644,910
|
|
|
Other accrued
liabilities
|
1,468,468
|
|
1,645,552
|
|
|
Deferred income taxes
|
503,894
|
|
512,572
|
|
|
Deferred revenue
|
458,800
|
|
688,200
|
|
|
Total current
liabilities
|
4,459,143
|
|
4,491,234
|
|
|
|
|
|
|
|
Deferred revenue
|
-
|
|
114,700
|
|
|
|
|
|
|
|
Commitments and
contingencies
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
Preferred stock; $0.01 par
value; 1,500,000 shares
|
-
|
|
-
|
|
|
authorized; no shares
issued and outstanding
|
|
|
|
|
|
Series A preferred stock; $0.01
par value; 200,000 shares
|
-
|
|
-
|
|
|
authorized; no shares
issued and outstanding
|
|
|
|
|
|
Common stock; $0.01 par value;
30,000,000 shares
|
|
|
|
|
|
authorized; 10,427,878
shares issued at December 31,
|
|
|
|
|
|
2011 and June 30, 2011;
8,124,386 shares outstanding
|
|
|
|
|
|
at December 31, 2011 and
June 30, 2011
|
104,279
|
|
104,279
|
|
|
Additional paid-in
capital
|
48,520,798
|
|
48,499,103
|
|
|
Accumulated deficit
|
(834,820)
|
|
(712,542)
|
|
|
Less treasury stock, at cost;
2,303,492 shares at
|
|
|
|
|
|
December 31, 2011 and
June 30, 2011
|
(20,731,428)
|
|
(20,731,428)
|
|
|
Total stockholders'
equity
|
27,058,829
|
|
27,159,412
|
|
|
Total liabilities
and stockholders' equity
|
$
31,517,972
|
|
$
31,765,346
|
|
|
|
|
|
|
|
|
SOURCE Allied Healthcare Products